Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Jaarsveld, C. H.
Right arrow Articles by Bijlsma, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Jaarsveld, C. H.
Right arrow Articles by Bijlsma, J. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 37, 837-847, Copyright © 1998 by British Society for Rheumatology

ORIGINAL PAPERS

Direct cost of rheumatoid arthritis during the first six years: a cost- of-illness study

CH van Jaarsveld, JW Jacobs, AJ Schrijvers, AH Heurkens, HC Haanen and JW Bijlsma
Department of Rheumatology and Clinical Immunology, University Hospital Utrecht, The Netherlands.

The objective was to estimate the annual direct disease-related cost of rheumatoid arthritis (RA) during the first 6 yr and to determine which socio-demographic and clinical characteristics relate to these costs. The study population consisted of 424 RA patients who had participated in a (population-based) trial on therapeutic strategies for early RA since 1990 and were not lost to follow-up in April 1996. A questionnaire on costs due to RA was sent to these patients; 363 (86%) completed questionnaires were analysed. The total annual direct cost per patient was estimated by adding up the costs of health care workers, days admitted to care facilities, medication, monitoring for side-effects, alternative medicine, adaptations in the home, devices, and other direct costs such as travelling expenses. The mean annual direct cost due to RA was estimated to be Dfl. 11,550 per patient. An obvious increase in direct cost with increasing disease duration was not found. Patients with higher disease activity exhibited significantly higher costs compared to patients with lower disease activity. A multiple logistic regression model showed that greater disability and lower age increased the odds for high costs. The annual direct cost of RA averaged out at Dfl. 11,550 per patient (i.e. Pound Sterling 3680). A high total direct cost in the first 6 yr of disease is related to severe functional disability and lower age.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Med Decis MakingHome page
B. Fautrel, A. E. Clarke, F. Guillemin, V. Adam, Y. St-Pierre, T. Panaritis, P. R. Fortin, H. A. Menard, C. Donaldson, and J. R. Penrod
Costs of Rheumatoid Arthritis: New Estimates from the Human Capital Method and Comparison to the Willingness-to-Pay Method
Med Decis Making, March 1, 2007; 27(2): 138 - 150.
[Abstract] [PDF]

Home page
 Rheumatology (Oxford)Home page
E. Hallert, M. Husberg, D. Jonsson, and T. Skogh
Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project)
Rheumatology, November 1, 2004; 43(11): 1374 - 1382.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
S M M Verstappen, H Verkleij, J W J Bijlsma, E Buskens, A A Kruize, A H M Heurkens, M J van der Veen, and J W G Jacobs
Determinants of direct costs in Dutch rheumatoid arthritis patients
Ann Rheum Dis, July 1, 2004; 63(7): 817 - 824.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
J Ruof, J L Hulsemann, T Mittendorf, S Handelmann, J M von der Schulenburg, H Zeidler, and S Merkesdal
Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources
Ann Rheum Dis, June 1, 2003; 62(6): 544 - 549.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
W B van den Hout, G J Tijhuis, J M W Hazes, F C Breedveld, and T P M Vliet Vlieland
Cost effectiveness and cost utility analysis of multidisciplinary care in patients with rheumatoid arthritis: a randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care
Ann Rheum Dis, April 1, 2003; 62(4): 308 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
H M Lapsley, L M March, K L Tribe, M J Cross, B G Courtenay, and P M Brooks
Living with rheumatoid arthritis: expenditures, health status, and social impact on patients
Ann Rheum Dis, September 1, 2002; 61(9): 818 - 821.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
N. J. Cooper, M. Mugford, D. P. M. Symmons, E. M. Barrett, and D. G. I. Scott
Total costs and predictors of costs in individuals with early inflammatory polyarthritis: a community-based prospective study
Rheumatology, July 1, 2002; 41(7): 767 - 774.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
A. O. Frank and M. A. Chamberlain
Keeping our patients at work: implications for the management of those with rheumatoid arthritis and musculoskeletal conditions
Rheumatology, November 1, 2001; 40(11): 1201 - 1205.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
N. Sutcliffe, A. E. Clarke, R. Taylor, C. Frost, and D. A. Isenberg
Total costs and predictors of costs in patients with systemic lupus erythematosus
Rheumatology, January 1, 2001; 40(1): 37 - 47.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.